nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Ataxia—Altretamine—ovarian cancer	0.0349	0.0353	CcSEcCtD
Levobunolol—Rash generalised—Paclitaxel—ovarian cancer	0.0219	0.0221	CcSEcCtD
Levobunolol—Rash generalised—Docetaxel—ovarian cancer	0.0185	0.0188	CcSEcCtD
Levobunolol—Respiratory failure—Topotecan—ovarian cancer	0.0165	0.0167	CcSEcCtD
Levobunolol—Keratitis—Paclitaxel—ovarian cancer	0.0143	0.0145	CcSEcCtD
Levobunolol—Respiratory failure—Vinorelbine—ovarian cancer	0.0141	0.0142	CcSEcCtD
Levobunolol—Asthenia—Altretamine—ovarian cancer	0.0131	0.0132	CcSEcCtD
Levobunolol—Ataxia—Chlorambucil—ovarian cancer	0.0124	0.0125	CcSEcCtD
Levobunolol—Dizziness—Altretamine—ovarian cancer	0.0121	0.0122	CcSEcCtD
Levobunolol—Lethargy—Topotecan—ovarian cancer	0.012	0.0121	CcSEcCtD
Levobunolol—Cardiac arrest—Topotecan—ovarian cancer	0.0112	0.0113	CcSEcCtD
Levobunolol—Cardiac arrest—Melphalan—ovarian cancer	0.0109	0.0111	CcSEcCtD
Levobunolol—Nausea—Altretamine—ovarian cancer	0.0108	0.011	CcSEcCtD
Levobunolol—Pain—Carboplatin—ovarian cancer	0.0108	0.0109	CcSEcCtD
Levobunolol—Cerebrovascular accident—Vinorelbine—ovarian cancer	0.0102	0.0104	CcSEcCtD
Levobunolol—Lethargy—Vinorelbine—ovarian cancer	0.0102	0.0104	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.0101	0.0102	CcSEcCtD
Levobunolol—Bronchospasm—Melphalan—ovarian cancer	0.00977	0.00988	CcSEcCtD
Levobunolol—Atrioventricular block—Paclitaxel—ovarian cancer	0.00959	0.0097	CcSEcCtD
Levobunolol—Respiratory failure—Paclitaxel—ovarian cancer	0.00947	0.00958	CcSEcCtD
Levobunolol—Erythema multiforme—Chlorambucil—ovarian cancer	0.00862	0.00872	CcSEcCtD
Levobunolol—Bronchospasm—Vinorelbine—ovarian cancer	0.00853	0.00864	CcSEcCtD
Levobunolol—Keratitis—Epirubicin—ovarian cancer	0.0082	0.0083	CcSEcCtD
Levobunolol—Alopecia—Chlorambucil—ovarian cancer	0.00806	0.00815	CcSEcCtD
Levobunolol—Respiratory failure—Docetaxel—ovarian cancer	0.00803	0.00812	CcSEcCtD
Levobunolol—Keratitis—Doxorubicin—ovarian cancer	0.00759	0.00768	CcSEcCtD
Levobunolol—Cardiac failure congestive—Paclitaxel—ovarian cancer	0.00745	0.00753	CcSEcCtD
Levobunolol—Nasal congestion—Paclitaxel—ovarian cancer	0.00741	0.0075	CcSEcCtD
Levobunolol—Alopecia—Topotecan—ovarian cancer	0.00717	0.00726	CcSEcCtD
Levobunolol—Visual disturbance—Paclitaxel—ovarian cancer	0.00713	0.00721	CcSEcCtD
Levobunolol—Arrhythmia—Melphalan—ovarian cancer	0.0071	0.00719	CcSEcCtD
Levobunolol—Alopecia—Melphalan—ovarian cancer	0.00702	0.00711	CcSEcCtD
Levobunolol—Hypoglycaemia—Paclitaxel—ovarian cancer	0.00692	0.007	CcSEcCtD
Levobunolol—Lethargy—Paclitaxel—ovarian cancer	0.00689	0.00697	CcSEcCtD
Levobunolol—Cerebrovascular accident—Paclitaxel—ovarian cancer	0.00689	0.00697	CcSEcCtD
Levobunolol—Stinging—Epirubicin—ovarian cancer	0.00656	0.00664	CcSEcCtD
Levobunolol—Confusional state—Chlorambucil—ovarian cancer	0.00653	0.00661	CcSEcCtD
Levobunolol—Cardiac arrest—Paclitaxel—ovarian cancer	0.00642	0.0065	CcSEcCtD
Levobunolol—Ataxia—Paclitaxel—ovarian cancer	0.00635	0.00642	CcSEcCtD
Levobunolol—Cardiac failure congestive—Docetaxel—ovarian cancer	0.00631	0.00639	CcSEcCtD
Levobunolol—Arrhythmia—Vinorelbine—ovarian cancer	0.0062	0.00628	CcSEcCtD
Levobunolol—Alopecia—Vinorelbine—ovarian cancer	0.00614	0.00621	CcSEcCtD
Levobunolol—Stinging—Doxorubicin—ovarian cancer	0.00607	0.00615	CcSEcCtD
Levobunolol—Visual disturbance—Docetaxel—ovarian cancer	0.00604	0.00611	CcSEcCtD
Levobunolol—Chest pain—Topotecan—ovarian cancer	0.00602	0.00609	CcSEcCtD
Levobunolol—Chest pain—Melphalan—ovarian cancer	0.00589	0.00596	CcSEcCtD
Levobunolol—Lethargy—Docetaxel—ovarian cancer	0.00584	0.00591	CcSEcCtD
Levobunolol—Timolol—ABCB1—ovarian cancer	0.00567	0.484	CrCbGaD
Levobunolol—Pain—Chlorambucil—ovarian cancer	0.00554	0.00561	CcSEcCtD
Levobunolol—Atrioventricular block—Epirubicin—ovarian cancer	0.00548	0.00555	CcSEcCtD
Levobunolol—Ataxia—Docetaxel—ovarian cancer	0.00538	0.00545	CcSEcCtD
Levobunolol—Palpitations—Vinorelbine—ovarian cancer	0.00534	0.00541	CcSEcCtD
Levobunolol—Feeling abnormal—Chlorambucil—ovarian cancer	0.00534	0.0054	CcSEcCtD
Levobunolol—Hypotension—Melphalan—ovarian cancer	0.00528	0.00534	CcSEcCtD
Levobunolol—Depression—Paclitaxel—ovarian cancer	0.00519	0.00525	CcSEcCtD
Levobunolol—Paraesthesia—Topotecan—ovarian cancer	0.00518	0.00524	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00516	0.00522	CcSEcCtD
Levobunolol—Urticaria—Chlorambucil—ovarian cancer	0.00515	0.00521	CcSEcCtD
Levobunolol—Chest pain—Vinorelbine—ovarian cancer	0.00515	0.00521	CcSEcCtD
Levobunolol—Dyspnoea—Topotecan—ovarian cancer	0.00514	0.0052	CcSEcCtD
Levobunolol—Atrioventricular block—Doxorubicin—ovarian cancer	0.00507	0.00513	CcSEcCtD
Levobunolol—Paraesthesia—Melphalan—ovarian cancer	0.00507	0.00513	CcSEcCtD
Levobunolol—Conjunctivitis—Paclitaxel—ovarian cancer	0.00506	0.00512	CcSEcCtD
Levobunolol—Dyspnoea—Melphalan—ovarian cancer	0.00503	0.00509	CcSEcCtD
Levobunolol—Pain—Topotecan—ovarian cancer	0.00493	0.00499	CcSEcCtD
Levobunolol—Bronchospasm—Docetaxel—ovarian cancer	0.00487	0.00492	CcSEcCtD
Levobunolol—Pain—Melphalan—ovarian cancer	0.00483	0.00489	CcSEcCtD
Levobunolol—Hypersensitivity—Chlorambucil—ovarian cancer	0.00477	0.00483	CcSEcCtD
Levobunolol—Bradycardia—Paclitaxel—ovarian cancer	0.00476	0.00481	CcSEcCtD
Levobunolol—Feeling abnormal—Topotecan—ovarian cancer	0.00475	0.00481	CcSEcCtD
Levobunolol—Asthenia—Chlorambucil—ovarian cancer	0.00465	0.0047	CcSEcCtD
Levobunolol—Hypotension—Vinorelbine—ovarian cancer	0.00461	0.00467	CcSEcCtD
Levobunolol—Pruritus—Chlorambucil—ovarian cancer	0.00458	0.00464	CcSEcCtD
Levobunolol—Urticaria—Topotecan—ovarian cancer	0.00458	0.00464	CcSEcCtD
Levobunolol—Nadolol—ABCB1—ovarian cancer	0.00451	0.384	CrCbGaD
Levobunolol—Visual impairment—Paclitaxel—ovarian cancer	0.0045	0.00455	CcSEcCtD
Levobunolol—Urticaria—Melphalan—ovarian cancer	0.00449	0.00454	CcSEcCtD
Levobunolol—Diabetes mellitus—Epirubicin—ovarian cancer	0.00444	0.00449	CcSEcCtD
Levobunolol—Diarrhoea—Chlorambucil—ovarian cancer	0.00443	0.00449	CcSEcCtD
Levobunolol—Paraesthesia—Vinorelbine—ovarian cancer	0.00443	0.00448	CcSEcCtD
Levobunolol—Erythema multiforme—Paclitaxel—ovarian cancer	0.00442	0.00447	CcSEcCtD
Levobunolol—Dyspnoea—Vinorelbine—ovarian cancer	0.0044	0.00445	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00437	0.00442	CcSEcCtD
Levobunolol—Conjunctivitis—Docetaxel—ovarian cancer	0.00429	0.00434	CcSEcCtD
Levobunolol—Cardiac failure congestive—Epirubicin—ovarian cancer	0.00426	0.00431	CcSEcCtD
Levobunolol—Hypersensitivity—Topotecan—ovarian cancer	0.00425	0.0043	CcSEcCtD
Levobunolol—Pain—Vinorelbine—ovarian cancer	0.00422	0.00427	CcSEcCtD
Levobunolol—Arrhythmia—Paclitaxel—ovarian cancer	0.00417	0.00422	CcSEcCtD
Levobunolol—Hypersensitivity—Melphalan—ovarian cancer	0.00416	0.00421	CcSEcCtD
Levobunolol—Asthenia—Topotecan—ovarian cancer	0.00414	0.00419	CcSEcCtD
Levobunolol—Alopecia—Paclitaxel—ovarian cancer	0.00413	0.00418	CcSEcCtD
Levobunolol—Diabetes mellitus—Doxorubicin—ovarian cancer	0.00411	0.00416	CcSEcCtD
Levobunolol—Pruritus—Topotecan—ovarian cancer	0.00408	0.00413	CcSEcCtD
Levobunolol—Feeling abnormal—Vinorelbine—ovarian cancer	0.00407	0.00411	CcSEcCtD
Levobunolol—Asthenia—Melphalan—ovarian cancer	0.00405	0.0041	CcSEcCtD
Levobunolol—Pruritus—Melphalan—ovarian cancer	0.004	0.00404	CcSEcCtD
Levobunolol—Hypoglycaemia—Epirubicin—ovarian cancer	0.00396	0.004	CcSEcCtD
Levobunolol—Diarrhoea—Topotecan—ovarian cancer	0.00395	0.00399	CcSEcCtD
Levobunolol—Cerebrovascular accident—Epirubicin—ovarian cancer	0.00394	0.00399	CcSEcCtD
Levobunolol—Lethargy—Epirubicin—ovarian cancer	0.00394	0.00399	CcSEcCtD
Levobunolol—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00394	0.00399	CcSEcCtD
Levobunolol—Urticaria—Vinorelbine—ovarian cancer	0.00392	0.00397	CcSEcCtD
Levobunolol—Diarrhoea—Melphalan—ovarian cancer	0.00386	0.00391	CcSEcCtD
Levobunolol—Diplopia—Epirubicin—ovarian cancer	0.00386	0.00391	CcSEcCtD
Levobunolol—Nausea—Chlorambucil—ovarian cancer	0.00385	0.00389	CcSEcCtD
Levobunolol—Visual impairment—Docetaxel—ovarian cancer	0.00382	0.00386	CcSEcCtD
Levobunolol—Dizziness—Topotecan—ovarian cancer	0.00381	0.00386	CcSEcCtD
Levobunolol—Erythema multiforme—Docetaxel—ovarian cancer	0.00374	0.00379	CcSEcCtD
Levobunolol—Cardiac arrest—Epirubicin—ovarian cancer	0.00367	0.00371	CcSEcCtD
Levobunolol—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00366	0.0037	CcSEcCtD
Levobunolol—Syncope—Paclitaxel—ovarian cancer	0.00365	0.00369	CcSEcCtD
Levobunolol—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.00364	0.00369	CcSEcCtD
Levobunolol—Lethargy—Doxorubicin—ovarian cancer	0.00364	0.00369	CcSEcCtD
Levobunolol—Hypersensitivity—Vinorelbine—ovarian cancer	0.00364	0.00368	CcSEcCtD
Levobunolol—Ataxia—Epirubicin—ovarian cancer	0.00363	0.00367	CcSEcCtD
Levobunolol—Headache—Topotecan—ovarian cancer	0.00361	0.00366	CcSEcCtD
Levobunolol—Palpitations—Paclitaxel—ovarian cancer	0.00359	0.00364	CcSEcCtD
Levobunolol—Loss of consciousness—Paclitaxel—ovarian cancer	0.00357	0.00362	CcSEcCtD
Levobunolol—Diplopia—Doxorubicin—ovarian cancer	0.00357	0.00361	CcSEcCtD
Levobunolol—Asthenia—Vinorelbine—ovarian cancer	0.00354	0.00358	CcSEcCtD
Levobunolol—Arrhythmia—Docetaxel—ovarian cancer	0.00354	0.00358	CcSEcCtD
Levobunolol—Alopecia—Docetaxel—ovarian cancer	0.0035	0.00354	CcSEcCtD
Levobunolol—Pruritus—Vinorelbine—ovarian cancer	0.00349	0.00353	CcSEcCtD
Levobunolol—Chest pain—Paclitaxel—ovarian cancer	0.00346	0.0035	CcSEcCtD
Levobunolol—Nausea—Topotecan—ovarian cancer	0.00343	0.00347	CcSEcCtD
Levobunolol—Cardiac arrest—Doxorubicin—ovarian cancer	0.0034	0.00344	CcSEcCtD
Levobunolol—Diarrhoea—Vinorelbine—ovarian cancer	0.00338	0.00342	CcSEcCtD
Levobunolol—Ataxia—Doxorubicin—ovarian cancer	0.00336	0.0034	CcSEcCtD
Levobunolol—Nausea—Melphalan—ovarian cancer	0.00335	0.00339	CcSEcCtD
Levobunolol—Confusional state—Paclitaxel—ovarian cancer	0.00335	0.00339	CcSEcCtD
Levobunolol—Shock—Paclitaxel—ovarian cancer	0.00326	0.0033	CcSEcCtD
Levobunolol—Dizziness—Vinorelbine—ovarian cancer	0.00326	0.0033	CcSEcCtD
Levobunolol—Hypotension—Paclitaxel—ovarian cancer	0.0031	0.00314	CcSEcCtD
Levobunolol—Headache—Vinorelbine—ovarian cancer	0.00309	0.00313	CcSEcCtD
Levobunolol—Syncope—Docetaxel—ovarian cancer	0.00309	0.00313	CcSEcCtD
Levobunolol—Palpitations—Docetaxel—ovarian cancer	0.00305	0.00308	CcSEcCtD
Levobunolol—Loss of consciousness—Docetaxel—ovarian cancer	0.00303	0.00307	CcSEcCtD
Levobunolol—Paraesthesia—Paclitaxel—ovarian cancer	0.00298	0.00302	CcSEcCtD
Levobunolol—Dyspnoea—Paclitaxel—ovarian cancer	0.00296	0.00299	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00295	0.00298	CcSEcCtD
Levobunolol—Chest pain—Docetaxel—ovarian cancer	0.00293	0.00297	CcSEcCtD
Levobunolol—Nausea—Vinorelbine—ovarian cancer	0.00293	0.00297	CcSEcCtD
Levobunolol—Conjunctivitis—Epirubicin—ovarian cancer	0.00289	0.00293	CcSEcCtD
Levobunolol—Pain—Paclitaxel—ovarian cancer	0.00284	0.00287	CcSEcCtD
Levobunolol—Confusional state—Docetaxel—ovarian cancer	0.00284	0.00287	CcSEcCtD
Levobunolol—Shock—Docetaxel—ovarian cancer	0.00277	0.0028	CcSEcCtD
Levobunolol—Feeling abnormal—Paclitaxel—ovarian cancer	0.00273	0.00277	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00273	0.00276	CcSEcCtD
Levobunolol—Bradycardia—Epirubicin—ovarian cancer	0.00272	0.00275	CcSEcCtD
Levobunolol—Conjunctivitis—Doxorubicin—ovarian cancer	0.00268	0.00271	CcSEcCtD
Levobunolol—Urticaria—Paclitaxel—ovarian cancer	0.00264	0.00267	CcSEcCtD
Levobunolol—Hypotension—Docetaxel—ovarian cancer	0.00263	0.00266	CcSEcCtD
Levobunolol—Visual impairment—Epirubicin—ovarian cancer	0.00257	0.0026	CcSEcCtD
Levobunolol—Paraesthesia—Docetaxel—ovarian cancer	0.00253	0.00256	CcSEcCtD
Levobunolol—Erythema multiforme—Epirubicin—ovarian cancer	0.00252	0.00255	CcSEcCtD
Levobunolol—Bradycardia—Doxorubicin—ovarian cancer	0.00252	0.00255	CcSEcCtD
Levobunolol—Dyspnoea—Docetaxel—ovarian cancer	0.00251	0.00254	CcSEcCtD
Levobunolol—Hypersensitivity—Paclitaxel—ovarian cancer	0.00245	0.00247	CcSEcCtD
Levobunolol—Pain—Docetaxel—ovarian cancer	0.00241	0.00243	CcSEcCtD
Levobunolol—Arrhythmia—Epirubicin—ovarian cancer	0.00239	0.00241	CcSEcCtD
Levobunolol—Visual impairment—Doxorubicin—ovarian cancer	0.00238	0.00241	CcSEcCtD
Levobunolol—Asthenia—Paclitaxel—ovarian cancer	0.00238	0.00241	CcSEcCtD
Levobunolol—Alopecia—Epirubicin—ovarian cancer	0.00236	0.00239	CcSEcCtD
Levobunolol—Pruritus—Paclitaxel—ovarian cancer	0.00235	0.00238	CcSEcCtD
Levobunolol—Erythema multiforme—Doxorubicin—ovarian cancer	0.00234	0.00236	CcSEcCtD
Levobunolol—Feeling abnormal—Docetaxel—ovarian cancer	0.00232	0.00235	CcSEcCtD
Levobunolol—Diarrhoea—Paclitaxel—ovarian cancer	0.00227	0.0023	CcSEcCtD
Levobunolol—Arrhythmia—Doxorubicin—ovarian cancer	0.00221	0.00223	CcSEcCtD
Levobunolol—Dizziness—Paclitaxel—ovarian cancer	0.00219	0.00222	CcSEcCtD
Levobunolol—Alopecia—Doxorubicin—ovarian cancer	0.00218	0.00221	CcSEcCtD
Levobunolol—Syncope—Epirubicin—ovarian cancer	0.00208	0.00211	CcSEcCtD
Levobunolol—Headache—Paclitaxel—ovarian cancer	0.00208	0.0021	CcSEcCtD
Levobunolol—Hypersensitivity—Docetaxel—ovarian cancer	0.00207	0.0021	CcSEcCtD
Levobunolol—Palpitations—Epirubicin—ovarian cancer	0.00205	0.00208	CcSEcCtD
Levobunolol—Loss of consciousness—Epirubicin—ovarian cancer	0.00204	0.00207	CcSEcCtD
Levobunolol—Asthenia—Docetaxel—ovarian cancer	0.00202	0.00204	CcSEcCtD
Levobunolol—Pruritus—Docetaxel—ovarian cancer	0.00199	0.00201	CcSEcCtD
Levobunolol—Chest pain—Epirubicin—ovarian cancer	0.00198	0.002	CcSEcCtD
Levobunolol—Nausea—Paclitaxel—ovarian cancer	0.00197	0.00199	CcSEcCtD
Levobunolol—Syncope—Doxorubicin—ovarian cancer	0.00193	0.00195	CcSEcCtD
Levobunolol—Diarrhoea—Docetaxel—ovarian cancer	0.00192	0.00195	CcSEcCtD
Levobunolol—Confusional state—Epirubicin—ovarian cancer	0.00191	0.00194	CcSEcCtD
Levobunolol—Palpitations—Doxorubicin—ovarian cancer	0.0019	0.00192	CcSEcCtD
Levobunolol—Loss of consciousness—Doxorubicin—ovarian cancer	0.00189	0.00191	CcSEcCtD
Levobunolol—Shock—Epirubicin—ovarian cancer	0.00187	0.00189	CcSEcCtD
Levobunolol—Dizziness—Docetaxel—ovarian cancer	0.00186	0.00188	CcSEcCtD
Levobunolol—Chest pain—Doxorubicin—ovarian cancer	0.00183	0.00185	CcSEcCtD
Levobunolol—Hypotension—Epirubicin—ovarian cancer	0.00177	0.00179	CcSEcCtD
Levobunolol—Confusional state—Doxorubicin—ovarian cancer	0.00177	0.00179	CcSEcCtD
Levobunolol—Headache—Docetaxel—ovarian cancer	0.00176	0.00178	CcSEcCtD
Levobunolol—Shock—Doxorubicin—ovarian cancer	0.00173	0.00175	CcSEcCtD
Levobunolol—Paraesthesia—Epirubicin—ovarian cancer	0.0017	0.00172	CcSEcCtD
Levobunolol—Dyspnoea—Epirubicin—ovarian cancer	0.00169	0.00171	CcSEcCtD
Levobunolol—Nausea—Docetaxel—ovarian cancer	0.00167	0.00169	CcSEcCtD
Levobunolol—Hypotension—Doxorubicin—ovarian cancer	0.00164	0.00166	CcSEcCtD
Levobunolol—Pain—Epirubicin—ovarian cancer	0.00162	0.00164	CcSEcCtD
Levobunolol—Paraesthesia—Doxorubicin—ovarian cancer	0.00158	0.0016	CcSEcCtD
Levobunolol—Dyspnoea—Doxorubicin—ovarian cancer	0.00157	0.00158	CcSEcCtD
Levobunolol—Feeling abnormal—Epirubicin—ovarian cancer	0.00156	0.00158	CcSEcCtD
Levobunolol—Propranolol—ABCB1—ovarian cancer	0.00155	0.132	CrCbGaD
Levobunolol—Urticaria—Epirubicin—ovarian cancer	0.00151	0.00153	CcSEcCtD
Levobunolol—Pain—Doxorubicin—ovarian cancer	0.0015	0.00152	CcSEcCtD
Levobunolol—Feeling abnormal—Doxorubicin—ovarian cancer	0.00145	0.00146	CcSEcCtD
Levobunolol—Hypersensitivity—Epirubicin—ovarian cancer	0.0014	0.00141	CcSEcCtD
Levobunolol—Urticaria—Doxorubicin—ovarian cancer	0.00139	0.00141	CcSEcCtD
Levobunolol—Asthenia—Epirubicin—ovarian cancer	0.00136	0.00138	CcSEcCtD
Levobunolol—Pruritus—Epirubicin—ovarian cancer	0.00134	0.00136	CcSEcCtD
Levobunolol—Diarrhoea—Epirubicin—ovarian cancer	0.0013	0.00131	CcSEcCtD
Levobunolol—Hypersensitivity—Doxorubicin—ovarian cancer	0.00129	0.00131	CcSEcCtD
Levobunolol—Asthenia—Doxorubicin—ovarian cancer	0.00126	0.00127	CcSEcCtD
Levobunolol—Dizziness—Epirubicin—ovarian cancer	0.00125	0.00127	CcSEcCtD
Levobunolol—Pruritus—Doxorubicin—ovarian cancer	0.00124	0.00126	CcSEcCtD
Levobunolol—Diarrhoea—Doxorubicin—ovarian cancer	0.0012	0.00122	CcSEcCtD
Levobunolol—Headache—Epirubicin—ovarian cancer	0.00119	0.0012	CcSEcCtD
Levobunolol—Dizziness—Doxorubicin—ovarian cancer	0.00116	0.00117	CcSEcCtD
Levobunolol—Nausea—Epirubicin—ovarian cancer	0.00113	0.00114	CcSEcCtD
Levobunolol—Headache—Doxorubicin—ovarian cancer	0.0011	0.00111	CcSEcCtD
Levobunolol—Nausea—Doxorubicin—ovarian cancer	0.00104	0.00106	CcSEcCtD
